Litton W Edwin 4

Accession 0001181431-10-005145

CIK 0001295976other

View on SEC.gov Company Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 3:44 PM ET

Size

48.5 KB

Accession

0001181431-10-005145

Insider Transaction Report

Form 4

Period: 2010-01-27

Cellu Tissue Holdings, Inc.CLU

Litton W Edwin

Gen'l Counsel, Sr. V.P.

Transactions

Exercise/Conversion
Common Stock
2010-01-27$2.55/sh+1,017$2,593→ 1,017 total
Exercise/Conversion
Common Stock
2010-01-27$5.64/sh+339$1,912→ 3,051 total
Disposition to Issuer
Common Stock
2010-01-27$13.00/sh−7,558$98,254→ 0 total
Other
Employee Stock Option
2010-01-27+4,181→ 4,181 total
Exercise: $2.55Exp: 2016-12-03→ Common Stock (4,181 underlying)
Other
Employee Stock Option
2010-01-27+4,181→ 4,181 total
Exercise: $5.85Exp: 2017-04-09→ Common Stock (4,181 underlying)
Other
Employee Stock Option
2010-01-27−4,181→ 0 total
Exercise: $2.55Exp: 2016-08-15→ Common Stock (4,181 underlying)
Other
Employee Stock Option
2010-01-27−21,242→ 0 total
Exercise: $5.28Exp: 2019-04-13→ Common Stock (21,242 underlying)
Exercise/Conversion
Employee Stock Option
2010-01-27−1,017→ 2,118 total
Exercise: $2.55Exp: 2016-12-03→ Common Stock (4,181 underlying)
Exercise/Conversion
Employee Stock Option
2010-01-27−4,507→ 16,735 total
Exercise: $5.28Exp: 2019-04-13→ Common Stock (21,242 underlying)
Other
Employee Stock Option
2010-01-27+21,242→ 21,242 total
Exercise: $5.28Exp: 2019-04-13→ Common Stock (21,242 underlying)
Other
Employee Stock Option
2010-01-27−4,181→ 0 total
Exercise: $5.85Exp: 2017-04-08→ Common Stock (4,181 underlying)
Other
Employee Stock Option
2010-01-27−4,181→ 0 total
Exercise: $5.64Exp: 2018-04-07→ Common Stock (4,181 underlying)
Exercise/Conversion
Employee Stock Option
2010-01-27−1,017→ 2,118 total
Exercise: $2.55Exp: 2016-08-15→ Common Stock (4,181 underlying)
Exercise/Conversion
Employee Stock Option
2010-01-27−678→ 3,503 total
Exercise: $5.85Exp: 2017-04-09→ Common Stock (4,181 underlying)
Exercise/Conversion
Employee Stock Option
2010-01-27−339→ 3,842 total
Exercise: $5.64Exp: 2018-04-07→ Common Stock (4,181 underlying)
Exercise/Conversion
Common Stock
2010-01-27$5.85/sh+678$3,966→ 2,712 total
Exercise/Conversion
Common Stock
2010-01-27$5.28/sh+4,507$23,797→ 7,558 total
Other
Employee Stock Option
2010-01-27+4,181→ 4,181 total
Exercise: $2.55Exp: 2016-08-15→ Common Stock (4,181 underlying)
Exercise/Conversion
Common Stock
2010-01-27$2.55/sh+1,017$2,593→ 2,034 total
Other
Employee Stock Option
2010-01-27−4,181→ 0 total
Exercise: $2.55Exp: 2016-12-03→ Common Stock (4,181 underlying)
Award
Employee Stock Option
2010-01-27+9,706→ 9,706 total
Exercise: $11.45Exp: 2020-01-27→ Common Stock (9,706 underlying)
Exercise of In-Money
Put Right
2010-01-27−7,558→ 0 total
Exercise: $13.00→ Common Stock (7,558 underlying)
Other
Employee Stock Option
2010-01-27+4,181→ 4,181 total
Exercise: $5.64Exp: 2018-04-07→ Common Stock (4,181 underlying)

Footnotes (8)

[F1]Reporting person held options to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
[F2]Upon the exchange described in footnote 1, the option is vested as to 75% of the shares with vesting for the remaining shares to occur on August 15, 2010.
[F3]Upon the exchange described in footnote 1, the option is vested as to 75% of the shares with vesting for the remaining shares to occur on December 3, 2010.
[F4]Upon the exchange described in footnote 1, the option is vested as to 50% of the shares with vesting for the remaining shares to occur one-half each on April 1, 2010 and April 1, 2011.
[F5]Upon the exchange described in footnote 1, the option is vested as to 25% of the shares with vesting for the remaining shares to occur one-third each on April 7, 2010, April 7, 2011 and April 7, 2012.
[F6]Upon the exchange and the closing of the Issuer's initial public offering, described in footnote 1, options to purchase 13,883 shares are fully vested with vesting for the remaining shares to occur one-quarter each on April 13, 2010, April 13, 2011, April 13, 2012 and April 13, 2013.
[F7]Reporting Person exercised his right to put to the Issuer, at the initial public offering price, the number of shares receivable upon partial exercise of the various stock options shown above in Table II. The Issuer's compensation committee approved the terms of the put right.
[F8]Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.

Documents

1 file

4
rrd263815.xmlPrimary
IPO CONVERT/GRANTS

Issuer

Cellu Tissue Holdings, Inc.

CIK 0001295976

→

Entity typeother

Related Parties

filerCIK 0001480566

Filing Metadata

Form type: 4
Filed: Jan 27, 7:00 PM ET
Accepted: Jan 28, 3:44 PM ET
Size: 48.5 KB

View on SEC.gov